Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Teva Pharma Industries Ltd ADR (TEVAy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Teva ADR historical data, for real-time data please try another search
7.70 0.00    0.00%
02/10 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 7.55 / 7.79
  • Day's Range: 7.56 - 7.70
Type:  Equity
Market:  Germany
ISIN:  US8816242098 
S/N:  883035
Teva ADR 7.70 0.00 0.00%

TEVAy Balance Sheet

 
Assess the latest Teva balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced TEVA Annual Report data, financial summaries and charts are available for Teva Pharma Industries Ltd ADR investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2015
30/06
2015
31/03
2014
31/12
2014
30/09
Total Current Assets 13299 15711 14396 13922
Cash and Short Term Investments 1068 3396 2226 1473
Cash - - - -
Cash & Equivalents 1068 3396 2226 1473
Short Term Investments - - - -
Total Receivables, Net 5568 5508 5408 5410
Accounts Receivables - Trade, Net 5568 5508 5408 5410
Total Inventory 4226 4174 4371 4591
Prepaid Expenses - - - -
Other Current Assets, Total 2437 2633 2391 2448
Total Assets 50371 46951 46420 46608
Property/Plant/Equipment, Total - Net 6427 6349 6535 6551
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 19257 17936 18408 18720
Intangibles, Net 8215 5243 5512 5936
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 3173 1712 1569 1479
Other Assets, Total - - - -
Total Current Liabilities 14473 12467 12289 11669
Accounts Payable 2976 3036 3171 2894
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 3022 1626 1761 1832
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 8475 7805 7357 6943
Total Liabilities 27333 24315 23107 22975
Total Long Term Debt 9496 9391 8523 8818
Long Term Debt 9496 9391 8523 8818
Capital Lease Obligations - - - -
Deferred Income Tax 1976 1044 1101 1229
Minority Interest 47 41 42 37
Other Liabilities, Total 1341 1372 1152 1222
Total Equity 23038 22636 23313 23633
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total - - 50 -
Additional Paid-In Capital - - 14121 -
Retained Earnings (Accumulated Deficit) - - 14436 -
Treasury Stock - Common - - -3951 -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 23038 22636 -1343 23633
Total Liabilities & Shareholders' Equity 50371 46951 46420 46608
Total Common Shares Outstanding 852 852 852 854
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TEVA Price Commentary

Write your thoughts about Teva Pharmaceutical Industries Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rafi Shoev
Rafi Shoev 4 minutes ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva will probably sell this fectory that was asicret fore many years matorial for indestry fharma for a2or 3 bilian dolars.
Rafi Shoev
Rafi Shoev 1 hour ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
super biotecmology evry moment developing 40 mew medicstions.ItsTheTevaTime .i am not recomend any thing
Rafi Shoev
Rafi Shoev 1 hour ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Break point 14.4 .After the way to 19.its no any recomendations.
Rafi Shoev
Rafi Shoev 1 hour ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva Anda Ai.
Rafi Shoev
Rafi Shoev 3 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The money time for teva 8.5.24.
Rafi Shoev
Rafi Shoev May 02, 2024 16:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My privet no recomendation teva under valeu 300%
Rafi Shoev
Rafi Shoev May 02, 2024 14:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teba 2023 shoes future riportSowcaed Tenewd Sustainabilty Strategy and Ambitious Target.
Rafi Shoev
Rafi Shoev May 01, 2024 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva prduse more than 200 difrent medicatio.to more than 300 milion oeople ebry day.
Rafi Shoev
Rafi Shoev May 01, 2024 15:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva will soply madication to china
Rafi Shoev
Rafi Shoev Apr 30, 2024 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Teva will provide biosimilar to Humira in USA.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email